-
At the meeting Sunday, researchers from Europe are releasing new analysis of an old 1, 200-patient study testing Erbitux as initial treatment in combination with chemotherapy.
FORBES: ImClone Gets Targeted
-
In August ViroPharma of Exton, Pa. said data from an early-stage trial of its polymerase inhibitor reduced the virus 99% on average after 14 days of treatment in combination with interferon.
FORBES: Magazine Article
-
In August ViroPharma (nasdaq: VPHM - news - people ) of Exton, Pa. said data from an early-stage trial of its polymerase inhibitor reduced the virus 99% on average after 14 days of treatment in combination with interferon.
FORBES: Saving Your Liver
-
All the subjects told examiners that they were subjected to multiple forms of torture or ill treatment that "often occurred in combination over a long period of time, " the report says.
CNN: Report: Exams reveal abuse, torture of detainees
-
The NovoTTF-100A System is not intended to be used in combination with other cancer treatment.
ENGADGET: Portable brain tumor treatment system kills cancer while you take out the trash
-
There is no word on what the cost of a combination treatment will be should it succeed in larger trials.
FORBES: Independent Expert Likes Vertex CF Data
-
Which is why any serious progress in treatment and care of lung cancer requires a combination of better and earlier diagnosis with a more adequately funded research effort.
BBC: How under-funded is lung cancer research?
-
The 12 patients who took Vertex's drug in combination with interferon and ribavirin showed no sign of the virus after four weeks of treatment.
FORBES: Magazine Article
-
On Friday the drug was approved for use in combination with Aromasin for postmenopausal women with recurring HER2-negative breast cancer, after treatment with the drugs Femara and Arimidex.
MSN: FDA approves Afinitor for some breast cancers
-
VX-661 was generally well-tolerated, both as monotherapy and in combination with ivacaftor, and most adverse events were mild to moderate in severity and similar between the treatment groups and those who received placebo.
FORBES: Personalized Cystic Fibrosis Drugs Get A Booster Shot
-
In a development that greatly bolsters its standing in the cystic fibrosis market, Vertex Pharmaceuticals late yesterday released data showing a combination of its existing Kalydeco treatment and an experimental medication called VX-661 greatly improved patient breathing.
FORBES: Vertex Scores A Big Win With Its Cystic Fibrosis Experiment